financetom
Business
financetom
/
Business
/
Hindalco Industries to sell Kalwa land to Birla Estates for Rs 595 crore
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hindalco Industries to sell Kalwa land to Birla Estates for Rs 595 crore
Jul 12, 2023 11:49 AM

Aditya Birla Group's metals flagship Hindalco Industries Ltd on Wednesday, July 12, said the company is selling Kalwa land to Birla Estates Private Ltd for Rs 595 crore.

Share Market Live

NSE

The company said in an exchange filing that “Rs 595 crore to be received in multiple tranches over a period of time and 1.5 percent of the sales revenue.”

Birla Estates Private Ltd is a wholly-owned subsidiary of Century Textiles and Industries Ltd (CTIL).

"However, the transaction is being carried out on arm’s length basis, based on an Independent Valuation report, duly approved by the Audit Committee of the company," it said.

Hindalco Industries reported a 37 percent fall in its consolidated net profit to Rs 2,411 crore for the March quarter. The company posted a net profit of Rs 3,860 crore during the January-March quarter of 2021-22.

The total income of the company was Rs 56,209 crore in the quarter under review against Rs 56,057 crore in the year-ago quarter. Expenses were at Rs 53,372 crore, higher than Rs 51,026 crore a year ago.

Shares of Hindalco Industries Ltd ended at Rs 424.70, up by Rs 0.15, or 0.035 percent on the BSE.

(Edited by : Shoma Bhattacharjee)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Osino Resources Provides Update on Acquisition by Yintai Gold
Osino Resources Provides Update on Acquisition by Yintai Gold
Jun 20, 2024
12:02 PM EDT, 06/20/2024 (MT Newswires) -- Osino Resources ( OSIIF ) on Thursday provided an update on its $368-million acquisition by Yintai Gold. Yintai is offering for $1.90 in cash per Osino share. After receiving the third of three Chinese regulatory approvals on May 28, competition law clearance from the Namibia Competition Commission (NCC) remains the only outstanding approval...
Update: MediPharm Labs Acquires Rights for Advanced Medical Cannabis Products From Remidose Aerosols
Update: MediPharm Labs Acquires Rights for Advanced Medical Cannabis Products From Remidose Aerosols
Jun 20, 2024
11:57 AM EDT, 06/20/2024 (MT Newswires) -- MediPharm Labs ( MEDIF ) , a pharmaceutical company specializing in cannabinoids, on Thursday said it will acquire exclusive rights for advanced cannabis products from Remidose Aerosols. Under the agreement, MediPharm ( MEDIF ) will license global manufacturing, distribution and sales rights of a novel advanced medical cannabis technology from Remidose. The products...
US FDA proposes to remove switching study requirement for biosimilars
US FDA proposes to remove switching study requirement for biosimilars
Jun 20, 2024
June 20 (Reuters) - The U.S. Food and Drug Administration has proposed that biosimilar drugs seeking agency's interchangeable designation will no longer need studies showing the impact of switching between them and the branded drug. WHY IT'S IMPORTANT The designation allows pharmacists to substitute branded drugs with their close copies easily. AbbVie's ( ABBV ) top-selling arthritis drug Humira has...
Why Is Gilead Sciences Stock Trading Higher On Thursday?
Why Is Gilead Sciences Stock Trading Higher On Thursday?
Jun 20, 2024
Thursday, Gilead Sciences Inc ( GILD )  shared topline results from an interim analysis of its Phase 3 PURPOSE 1 trial indicating its twice-yearly injectable HIV-1 capsid inhibitor, lenacapavir, demonstrated 100% efficacy for the investigational use of HIV prevention in cisgender women. PURPOSE 1 study met its key efficacy endpoints of the superiority of twice-yearly lenacapavir to once-daily oral Truvada (emtricitabine...
Copyright 2023-2026 - www.financetom.com All Rights Reserved